Company intelligence / Profile preview

Sapu Bioscience

San Diego, California, United Statessapubio.com ↗

Ownership: Private
Development stage: Phase 2

Overview

Completed Phase 2 trials for pancreatic cancer, melanoma, and glioblastoma with reported robust efficacy and safety. Also developing treatments for COVID-19.

Therapeutic areas: OncologyInfectious Diseases
Modalities: RNA therapeuticssmall molecule drugsantisense oligodeoxynucleotide
Industry: Biotech

Drug pipeline

1 asset

OT-101

Phase 2

Indications: Cancer, DIPG, SARS-CoV-2

Beyond the preview

Go deeper on Sapu Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sapu Bioscience.